ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jia Dong
Matched on OpenAlex author ID A5102204967. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancer. Co-author DOI 10.1016/j.bbadis.2024.167346↗
- Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response and Survival Prediction in Pancreatic Can… Co-author DOI 10.3390/ijms24043270↗
- Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2020.188484↗
- Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. Co-author DOI 10.3390/cancers13153678↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianjun Yu · 4 shared papers, 2021–2024 · strength 0.64
- Paper BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T th… DOI 10.1016/j.bbadis.2024.167346↗
- Paper Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response a… DOI 10.3390/ijms24043270↗
- Paper Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. DOI 10.1016/j.bbcan.2020.188484↗
- Xuan Lin · 2 shared papers, 2021–2024 · strength 0.29
- Paper BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T th… DOI 10.1016/j.bbadis.2024.167346↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Heli Gao · 2 shared papers, 2021 · strength 0.27
- Wenquan Wang · 2 shared papers, 2021 · strength 0.27
- Liang Liu · 2 shared papers, 2021 · strength 0.27
- Yesiboli Tasiheng · 1 shared paper, 2024 · strength 0.18
- Mingjian Ma · 1 shared paper, 2024 · strength 0.18
- Yusheng Chen · 1 shared paper, 2024 · strength 0.18
- He Cheng · 1 shared paper, 2024 · strength 0.18
- Zhengjie Dai · 1 shared paper, 2024 · strength 0.18
- Chen Liu · 1 shared paper, 2024 · strength 0.18
- Wei Wang · 1 shared paper, 2023 · strength 0.18
- Qingcai Meng · 1 shared paper, 2023 · strength 0.18
- Miaoyan Wei · 1 shared paper, 2023 · strength 0.18
- Bo Zhang · 1 shared paper, 2023 · strength 0.18
- Jie Hua · 1 shared paper, 2023 · strength 0.18
- Jin Xu · 1 shared paper, 2023 · strength 0.18
- Chen Liang · 1 shared paper, 2023 · strength 0.18
- Xu Wang · 1 shared paper, 2021 · strength 0.10
- Wuhu Zhang · 1 shared paper, 2021 · strength 0.10
- Huaxiang Xu · 1 shared paper, 2021 · strength 0.10
- Xuan Han · 1 shared paper, 2021 · strength 0.10
- Hao Li · 1 shared paper, 2021 · strength 0.10
- Zhenyu Liao · 1 shared paper, 2021 · strength 0.10
- Long‐Yun Ye · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.